
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $648M | $770.5M | $899.9M | $975.8M | $908.3M | |
Revenue Growth (YoY) | -22.33% | 18.9% | 16.8% | 8.43% | -6.92% | |
Cost of Revenues | $493.8M | $603.6M | $725M | $774.5M | $719M | |
Gross Profit | $154.2M | $166.9M | $174.9M | $201.3M | $189.3M | |
Gross Profit Margin | 23.8% | 21.66% | 19.44% | 20.63% | 20.84% | |
R&D Expenses | $49.4M | $66.2M | $65.3M | $71.1M | $72.2M | |
Selling, General & Admin | $112.5M | $116M | $106.7M | $117.4M | $117.5M | |
Other Inc / (Exp) | $3.1M | $32.9M | -$6.5M | -$1.8M | $1.2M | |
Operating Expenses | $161.9M | $182.2M | $172M | $188.5M | $189.6M | |
Operating Income | -$7.7M | -$15.3M | $2.9M | $12.8M | -$381K | |
Net Interest Expenses | $6.1M | $5.2M | $7.1M | $13M | $14.4M | |
EBT. Incl. Unusual Items | -$10.7M | $12.4M | -$10.7M | -$1.9M | -$13.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.8M | $9M | $3.4M | $3.3M | $2.9M | |
Net Income to Company | -$8M | $3.4M | -$14.1M | -$5.2M | -$16.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8M | $3.4M | -$14.1M | -$5.2M | -$16.5M | |
Basic EPS (Cont. Ops) | -$0.29 | $0.13 | -$0.52 | -$0.19 | -$0.60 | |
Diluted EPS (Cont. Ops) | -$0.29 | $0.12 | -$0.52 | -$0.19 | -$0.60 | |
Weighted Average Basic Share | $27M | $27.1M | $27.3M | $27.4M | $27.6M | |
Weighted Average Diluted Share | $27M | $27.4M | $27.3M | $27.4M | $27.6M | |
EBITDA | $28.6M | $52.1M | $31.2M | $46M | $35.8M | |
EBIT | -$4.6M | $17.6M | -$3.6M | $11.1M | $850K | |
Revenue (Reported) | $648M | $770.5M | $899.9M | $975.8M | $908.3M | |
Operating Income (Reported) | -$7.7M | -$15.3M | $2.9M | $12.8M | -$381K | |
Operating Income (Adjusted) | -$4.6M | $17.6M | -$3.6M | $11.1M | $850K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $193.8M | $221.1M | $241.3M | $239.2M | $217.9M | |
Revenue Growth (YoY) | 5.92% | 14.07% | 9.17% | -0.9% | -8.89% | |
Cost of Revenues | $147.7M | $179.6M | $198.5M | $190.8M | $171.6M | |
Gross Profit | $46.1M | $41.4M | $42.8M | $48.4M | $46.3M | |
Gross Profit Margin | 23.78% | 18.75% | 17.74% | 20.22% | 21.25% | |
R&D Expenses | $14.7M | $17M | $17M | $17.6M | $17.8M | |
Selling, General & Admin | $29.4M | $27.4M | $29.9M | $30.4M | $31.7M | |
Other Inc / (Exp) | $256K | -$1.4M | -$1.3M | -$2.3M | $760K | |
Operating Expenses | $44M | $44.4M | $46.8M | $48M | $49.5M | |
Operating Income | $2.1M | -$3M | -$4M | $331K | -$3.2M | |
Net Interest Expenses | $1.8M | $1.8M | $2.7M | $3.6M | $3.2M | |
EBT. Incl. Unusual Items | $549K | -$6.2M | -$8.1M | -$5.6M | -$5.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $419K | $1.5M | -$708K | $510K | $1.6M | |
Net Income to Company | $130K | -$7.7M | -$7.4M | -$6.1M | -$7.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $130K | -$7.7M | -$7.4M | -$6.1M | -$7.2M | |
Basic EPS (Cont. Ops) | $0.00 | -$0.28 | -$0.27 | -$0.22 | -$0.26 | |
Diluted EPS (Cont. Ops) | $0.00 | -$0.28 | -$0.27 | -$0.22 | -$0.26 | |
Weighted Average Basic Share | $27M | $27.2M | $27.3M | $27.5M | $27.7M | |
Weighted Average Diluted Share | $27.5M | $27.2M | $27.3M | $27.5M | $27.7M | |
EBITDA | $10.9M | $4.8M | $3.2M | $6.8M | $5M | |
EBIT | $2.3M | -$4.4M | -$5.3M | -$2M | -$2.5M | |
Revenue (Reported) | $193.8M | $221.1M | $241.3M | $239.2M | $217.9M | |
Operating Income (Reported) | $2.1M | -$3M | -$4M | $331K | -$3.2M | |
Operating Income (Adjusted) | $2.3M | -$4.4M | -$5.3M | -$2M | -$2.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $658.8M | $797.7M | $920.2M | $973.7M | $887M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $504M | $635.5M | $743.9M | $766.8M | $699.8M | |
Gross Profit | $154.9M | $162.2M | $176.3M | $206.9M | $187.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $51.8M | $68.5M | $65.2M | $71.7M | $72.4M | |
Selling, General & Admin | $112.3M | $114M | $109.2M | $118M | $118.7M | |
Other Inc / (Exp) | $1.2M | $31.3M | -$6.4M | -$2.8M | $4.3M | |
Operating Expenses | $164.1M | $182.6M | $174.4M | $189.7M | $191.1M | |
Operating Income | -$9.3M | -$20.4M | $1.9M | $17.2M | -$3.9M | |
Net Interest Expenses | $6.9M | $5.2M | $8.1M | $13.9M | $14M | |
EBT. Incl. Unusual Items | -$14.9M | $5.7M | -$12.6M | $556K | -$13.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.6M | $10.1M | $1.2M | $4.5M | $4M | |
Net Income to Company | -$11.3M | -$4.4M | -$13.8M | -$3.9M | -$17.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$11.3M | -$4.4M | -$13.8M | -$3.9M | -$17.6M | |
Basic EPS (Cont. Ops) | -$0.42 | -$0.15 | -$0.51 | -$0.14 | -$0.64 | |
Diluted EPS (Cont. Ops) | -$0.42 | -$0.17 | -$0.51 | -$0.14 | -$0.64 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $25.7M | $46M | $29.5M | $49.6M | $34.1M | |
EBIT | -$8M | $10.9M | -$4.6M | $14.4M | $367K | |
Revenue (Reported) | $658.8M | $797.7M | $920.2M | $973.7M | $887M | |
Operating Income (Reported) | -$9.3M | -$20.4M | $1.9M | $17.2M | -$3.9M | |
Operating Income (Adjusted) | -$8M | $10.9M | -$4.6M | $14.4M | $367K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $193.8M | $221.1M | $241.3M | $239.2M | $217.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $147.7M | $179.6M | $198.5M | $190.8M | $171.6M | |
Gross Profit | $46.1M | $41.4M | $42.8M | $48.4M | $46.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $14.7M | $17M | $17M | $17.6M | $17.8M | |
Selling, General & Admin | $29.4M | $27.4M | $29.9M | $30.4M | $31.7M | |
Other Inc / (Exp) | $256K | -$1.4M | -$1.3M | -$2.3M | $760K | |
Operating Expenses | $44M | $44.4M | $46.8M | $48M | $49.5M | |
Operating Income | $2.1M | -$3M | -$4M | $331K | -$3.2M | |
Net Interest Expenses | $1.8M | $1.8M | $2.7M | $3.6M | $3.2M | |
EBT. Incl. Unusual Items | $549K | -$6.2M | -$8.1M | -$5.6M | -$5.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $419K | $1.5M | -$708K | $510K | $1.6M | |
Net Income to Company | $130K | -$7.7M | -$7.4M | -$6.1M | -$7.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $130K | -$7.7M | -$7.4M | -$6.1M | -$7.2M | |
Basic EPS (Cont. Ops) | $0.00 | -$0.28 | -$0.27 | -$0.22 | -$0.26 | |
Diluted EPS (Cont. Ops) | $0.00 | -$0.28 | -$0.27 | -$0.22 | -$0.26 | |
Weighted Average Basic Share | $27M | $27.2M | $27.3M | $27.5M | $27.7M | |
Weighted Average Diluted Share | $27.5M | $27.2M | $27.3M | $27.5M | $27.7M | |
EBITDA | $10.9M | $4.8M | $3.2M | $6.8M | $5M | |
EBIT | $2.3M | -$4.4M | -$5.3M | -$2M | -$2.5M | |
Revenue (Reported) | $193.8M | $221.1M | $241.3M | $239.2M | $217.9M | |
Operating Income (Reported) | $2.1M | -$3M | -$4M | $331K | -$3.2M | |
Operating Income (Adjusted) | $2.3M | -$4.4M | -$5.3M | -$2M | -$2.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $73.9M | $85.5M | $54.8M | $40.8M | $71.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $136.7M | $150.4M | $158.2M | $166.5M | $137.8M | |
Inventory | $90.5M | $138.1M | $152.6M | $187.8M | $151.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $33.5M | $36.8M | $44M | $34.2M | $26.6M | |
Total Current Assets | $334.7M | $410.8M | $409.6M | $429.4M | $387.5M | |
Property Plant And Equipment | $138.3M | $126.2M | $118.4M | $120.9M | $107.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $39.1M | $36.4M | $34.2M | $35.3M | $33.1M | |
Other Intangibles | $55.4M | $49.9M | $45.5M | $47.3M | $39.7M | |
Other Long-Term Assets | $54M | $42.1M | $44.4M | $47M | $53.6M | |
Total Assets | $621.4M | $665.4M | $652.1M | $679.9M | $621.6M | |
Accounts Payable | $86.1M | $97.7M | $110.2M | $111.9M | $83.5M | |
Accrued Expenses | $30.4M | $51.4M | $47M | $40.3M | $45.3M | |
Current Portion Of Long-Term Debt | $1.6M | -- | $1.5M | $2.1M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $146M | $173.1M | $177.7M | $178.2M | $150M | |
Long-Term Debt | $136M | $164M | $167.8M | $189.3M | $201.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $324.8M | $369.4M | $371.2M | $392.2M | $376.3M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$89.6M | -$97M | -$103.1M | -$92.8M | -$122M | |
Common Equity | $296.6M | $296M | $280.9M | $287.7M | $245.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $296.6M | $296M | $280.9M | $287.7M | $245.3M | |
Total Liabilities and Equity | $621.4M | $665.4M | $652.1M | $679.9M | $621.6M | |
Cash and Short Terms | $73.9M | $85.5M | $54.8M | $40.8M | $71.8M | |
Total Debt | $143.7M | $169.2M | $169.3M | $191.5M | $201.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $60.5M | $41.4M | $35.2M | $48.4M | $79.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $149.7M | $156M | $175.7M | $170.3M | $156.7M | |
Inventory | $95.4M | $148.4M | $168.7M | $179.9M | $151.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $37.5M | $50.6M | $43.6M | $32.7M | $30.4M | |
Total Current Assets | $343.1M | $396.3M | $423.1M | $431.3M | $418M | |
Property Plant And Equipment | $131.6M | $126.2M | $120.9M | $115.7M | $108.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $37.5M | $35.4M | $34.7M | $34.5M | $34.6M | |
Other Intangibles | $52.9M | $49.3M | $45.6M | $45.3M | $41.3M | |
Other Long-Term Assets | $56.2M | $43.6M | $46.4M | $48.6M | $54.6M | |
Total Assets | $621.5M | $650.8M | $670.7M | $675.4M | $657.4M | |
Accounts Payable | $88.9M | $102.6M | $132M | $109.2M | $97M | |
Accrued Expenses | $50.6M | $71.2M | $68.5M | $68.9M | $78.1M | |
Current Portion Of Long-Term Debt | $832K | -- | -- | $2.1M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $144.7M | $179M | $202M | $180.2M | $175.2M | |
Long-Term Debt | $153.5M | $147.7M | $167.4M | $194.4M | $203.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $336.8M | $356.9M | $394.5M | $398.2M | $404.3M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$100.5M | -$91.8M | -$99.3M | -$97.6M | -$107.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $284.7M | $293.9M | $276.2M | $277.3M | $253.1M | |
Total Liabilities and Equity | $621.5M | $650.8M | $670.7M | $675.4M | $657.4M | |
Cash and Short Terms | $60.5M | $41.4M | $35.2M | $48.4M | $79.1M | |
Total Debt | $158.7M | $152.9M | $168.8M | $196.5M | $203.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8M | $3.4M | -$14.1M | -$5.2M | -$16.5M | |
Depreciation & Amoritzation | $33.2M | $34.5M | $34.8M | $34.9M | $35M | |
Stock-Based Compensation | $5.9M | $6M | $5.9M | $3.3M | $4.1M | |
Change in Accounts Receivable | $4.2M | -$17M | -$13.2M | -$5.9M | $20.2M | |
Change in Inventories | $4M | -$51.3M | -$20.1M | -$31.6M | $26.9M | |
Cash From Operations | $28.6M | -$36.2M | $6.8M | $4.9M | $47.7M | |
Capital Expenditures | $32.5M | $27M | $31.6M | $38.5M | $24.3M | |
Cash Acquisitions | -- | $22.8M | -- | -- | -- | |
Cash From Investing | -$33.9M | $28M | -$28.6M | -$37M | -$24.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $112.6M | $137.7M | $60.5M | $153.1M | $167.2M | |
Long-Term Debt Repaid | -$99.3M | -$112.1M | -$60.2M | -$131.7M | -$155.2M | |
Repurchase of Common Stock | -$6.8M | -$2.7M | -$791K | -$1.7M | -$795K | |
Other Financing Activities | -- | -$18K | -$6.8M | -$2.3M | -- | |
Cash From Financing | $6.5M | $22.9M | -$7.3M | $17.5M | $11.1M | |
Beginning Cash (CF) | $69.4M | $73.9M | $85.5M | $54.8M | $40.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.3M | $14.7M | -$29.1M | -$14.5M | $34.4M | |
Ending Cash (CF) | $73.9M | $85.5M | $54.8M | $40.8M | $71.8M | |
Levered Free Cash Flow | -$3.8M | -$63.3M | -$24.8M | -$33.6M | $23.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $130K | -$7.7M | -$7.4M | -$6.1M | -$7.2M | |
Depreciation & Amoritzation | $8.6M | $9.2M | $8.5M | $8.8M | $7.5M | |
Stock-Based Compensation | $1.2M | $1.1M | $69K | $1.1M | $1.1M | |
Change in Accounts Receivable | -$16M | -$6.1M | -$16.8M | -$6.7M | -$14.6M | |
Change in Inventories | -$7.3M | -$9.8M | -$15.2M | $3.7M | $5.3M | |
Cash From Operations | -$17.1M | -$19.8M | -$9.2M | $9.1M | $10.9M | |
Capital Expenditures | $7.7M | $7.4M | $10.1M | $5.8M | $6.1M | |
Cash Acquisitions | $1.1M | -- | -- | -- | -- | |
Cash From Investing | -$6.9M | -$7.2M | -$8.8M | -$5.7M | -$6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $31.9M | $9.8M | $16.1M | $38.3M | $6.7M | |
Long-Term Debt Repaid | -$16.8M | -$26.3M | -$17M | -$32.3M | -$7.3M | |
Repurchase of Common Stock | -$2.3M | -$669K | -$1.2M | -$620K | -$226K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $12.8M | -$17.1M | -$2.1M | $5.4M | -$787K | |
Beginning Cash (CF) | $73.9M | $85.5M | $54.8M | $40.8M | $71.8M | |
Foreign Exchange Rate Adjustment | -$2.3M | $34K | $423K | -$1.2M | $3.2M | |
Additions / Reductions | -$11.2M | -$44.2M | -$20.1M | $8.8M | $4.1M | |
Ending Cash (CF) | $60.5M | $41.4M | $35.2M | $48.4M | $79.1M | |
Levered Free Cash Flow | -$24.8M | -$27.2M | -$19.3M | $3.3M | $4.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$11.3M | -$4.4M | -$13.8M | -$3.9M | -$17.6M | |
Depreciation & Amoritzation | $33.7M | $35.1M | $34.1M | $35.1M | $33.7M | |
Stock-Based Compensation | $5.7M | $5.9M | $4.9M | $4.3M | $4.1M | |
Change in Accounts Receivable | -$8.1M | -$7.2M | -$23.9M | $4.3M | $12.2M | |
Change in Inventories | $2.6M | -$53.8M | -$25.5M | -$12.6M | $28.5M | |
Cash From Operations | $18.1M | -$39M | $17.4M | $23.2M | $49.5M | |
Capital Expenditures | $33M | $26.7M | $34.4M | $34.2M | $24.6M | |
Cash Acquisitions | $1.1M | $21.8M | -- | -- | -- | |
Cash From Investing | -$33.7M | $27.7M | -$30.1M | -$33.9M | -$24.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $71.1M | $115.6M | $66.8M | $175.3M | $135.6M | |
Long-Term Debt Repaid | -$77.5M | -$121.7M | -$51M | -$146.9M | -$130.2M | |
Repurchase of Common Stock | -$2.4M | -$987K | -$1.3M | -$1.1M | -$401K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$8.9M | -$7.1M | $7.7M | $25M | $4.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$24.4M | -$18.4M | -$4.9M | $14.3M | $29.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$14.9M | -$65.7M | -$16.9M | -$10.9M | $25M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $130K | -$7.7M | -$7.4M | -$6.1M | -$7.2M | |
Depreciation & Amoritzation | $8.6M | $9.2M | $8.5M | $8.8M | $7.5M | |
Stock-Based Compensation | $1.2M | $1.1M | $69K | $1.1M | $1.1M | |
Change in Accounts Receivable | -$16M | -$6.1M | -$16.8M | -$6.7M | -$14.6M | |
Change in Inventories | -$7.3M | -$9.8M | -$15.2M | $3.7M | $5.3M | |
Cash From Operations | -$17.1M | -$19.8M | -$9.2M | $9.1M | $10.9M | |
Capital Expenditures | $7.7M | $7.4M | $10.1M | $5.8M | $6.1M | |
Cash Acquisitions | $1.1M | -- | -- | -- | -- | |
Cash From Investing | -$6.9M | -$7.2M | -$8.8M | -$5.7M | -$6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $31.9M | $9.8M | $16.1M | $38.3M | $6.7M | |
Long-Term Debt Repaid | -$16.8M | -$26.3M | -$17M | -$32.3M | -$7.3M | |
Repurchase of Common Stock | -$2.3M | -$669K | -$1.2M | -$620K | -$226K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $12.8M | -$17.1M | -$2.1M | $5.4M | -$787K | |
Beginning Cash (CF) | $73.9M | $85.5M | $54.8M | $40.8M | $71.8M | |
Foreign Exchange Rate Adjustment | -$2.3M | $34K | $423K | -$1.2M | $3.2M | |
Additions / Reductions | -$11.2M | -$44.2M | -$20.1M | $8.8M | $4.1M | |
Ending Cash (CF) | $60.5M | $41.4M | $35.2M | $48.4M | $79.1M | |
Levered Free Cash Flow | -$24.8M | -$27.2M | -$19.3M | $3.3M | $4.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.